STOCK TITAN
  1. Home
  2. Sec-filings
  3. COCO
  4. [Form 4] Vita Coco Company, Inc. Insider Trading Activity

Vita Coco (COCO) director trades 15,000 shares after stock option exercises

Filing Impact
(High)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

Vita Coco Company, Inc. director Jane Cecil Morreau reported option exercises and a related share sale. On February 23, 2026, she exercised non-qualified stock options in three steps, converting them into a total of 15,000 shares of common stock at $10.178 per share.

That same day she sold 15,000 shares of Vita Coco common stock at an average price of $53.91 per share in an open-market transaction executed under a Rule 10b5-1 trading plan. After these transactions, she directly owned 17,179 common shares of Vita Coco.

Positive

  • None.

Negative

  • None.
Insider Morreau Jane Cecil
Role Director
Sold 15,000 shs ($809K)
Type Security Shares Price Value
Exercise Non-Qualified Stock Option (Right to Buy) 5,000 $0.00 --
Exercise Non-Qualified Stock Option (Right to Buy) 5,000 $0.00 --
Exercise Non-Qualified Stock Option (Right to Buy) 5,000 $0.00 --
Exercise Common Stock 5,000 $10.178 $51K
Exercise Common Stock 5,000 $10.178 $51K
Exercise Common Stock 5,000 $10.178 $51K
Sale Common Stock 15,000 $53.91 $809K
Holdings After Transaction: Non-Qualified Stock Option (Right to Buy) — 40,500 shares (Direct); Common Stock — 22,179 shares (Direct)
Footnotes (1)
  1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The stock option is fully vested and currently exercisable.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
 Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Morreau Jane Cecil
(Last) (First) (Middle)
111 5TH AVENUE
2ND FLOOR
(Street)
NEW YORK NY 10003
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Vita Coco Company, Inc. [ COCO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 02/23/2026 M 5,000 A $10.178 22,179 D
Common Stock 02/23/2026 M 5,000 A $10.178 27,179 D
Common Stock 02/23/2026 M 5,000 A $10.178 32,179 D
Common Stock 02/23/2026 S(1) 15,000 D $53.91 17,179 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Non-Qualified Stock Option (Right to Buy) $10.178 02/23/2026 M 5,000 (2) 07/12/2031 Common Stock 5,000 $0 40,500 D
Non-Qualified Stock Option (Right to Buy) $10.178 02/23/2026 M 5,000 (2) 07/12/2031 Common Stock 5,000 $0 35,500 D
Non-Qualified Stock Option (Right to Buy) $10.178 02/23/2026 M 5,000 (2) 07/12/2031 Common Stock 5,000 $0 30,500 D
Explanation of Responses:
1. The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
2. The stock option is fully vested and currently exercisable.
Alison Klein, Attorney-in-Fact For: Jane Morreau 02/24/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Vita Coco (COCO) director Jane Cecil Morreau report?

Jane Cecil Morreau reported exercising stock options into 15,000 Vita Coco shares and selling 15,000 common shares. The transactions occurred on February 23, 2026 and were disclosed on a Form 4 insider ownership report.

How many Vita Coco (COCO) shares did the director sell and at what price?

She sold 15,000 shares of Vita Coco common stock at an average price of $53.91 per share. The transaction was classified as an open-market or private sale under transaction code “S.”

Were the Vita Coco (COCO) insider sales made under a 10b5-1 trading plan?

Yes, the filing states the sales of Vita Coco common stock were effected pursuant to a Rule 10b5-1 trading plan. Such plans pre-schedule trades, allowing insiders to systematically sell shares over time under predetermined conditions.

What option activity did the Vita Coco (COCO) director report on Form 4?

She reported exercising non-qualified stock options, classified with transaction code “M” for derivative exercise or conversion. These fully vested, currently exercisable options were converted into 15,000 shares of Vita Coco common stock on February 23, 2026.

How many Vita Coco (COCO) shares does the director hold after these transactions?

After completing the reported option exercises and share sale, the director directly owned 17,179 shares of Vita Coco common stock. This post-transaction balance reflects her remaining direct equity stake as shown in the Form 4 data.

Is the Vita Coco (COCO) director’s stock option already vested?

Yes, a footnote explains that the stock option is fully vested and currently exercisable. This means the director had the right to exercise the option immediately, enabling conversion into Vita Coco common shares before the reported sale.